JP2010514698A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010514698A5 JP2010514698A5 JP2009543249A JP2009543249A JP2010514698A5 JP 2010514698 A5 JP2010514698 A5 JP 2010514698A5 JP 2009543249 A JP2009543249 A JP 2009543249A JP 2009543249 A JP2009543249 A JP 2009543249A JP 2010514698 A5 JP2010514698 A5 JP 2010514698A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- fragment
- sequence
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 67
- 229920001184 polypeptide Polymers 0.000 claims 65
- 102000004196 processed proteins & peptides Human genes 0.000 claims 65
- 239000012634 fragment Substances 0.000 claims 42
- 238000000034 method Methods 0.000 claims 24
- 210000004027 cell Anatomy 0.000 claims 20
- 241000196324 Embryophyta Species 0.000 claims 17
- 108091033319 polynucleotide Proteins 0.000 claims 17
- 102000040430 polynucleotide Human genes 0.000 claims 17
- 239000002157 polynucleotide Substances 0.000 claims 17
- 230000005875 antibody response Effects 0.000 claims 13
- 230000003472 neutralizing effect Effects 0.000 claims 12
- 241000710886 West Nile virus Species 0.000 claims 9
- 208000015181 infectious disease Diseases 0.000 claims 9
- 230000002458 infectious effect Effects 0.000 claims 9
- 230000004044 response Effects 0.000 claims 6
- 241000700605 Viruses Species 0.000 claims 5
- 150000001413 amino acids Chemical class 0.000 claims 5
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 4
- 238000003556 assay Methods 0.000 claims 4
- 230000028993 immune response Effects 0.000 claims 4
- 239000013598 vector Substances 0.000 claims 4
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims 3
- 230000007124 immune defense Effects 0.000 claims 3
- 238000003018 immunoassay Methods 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 2
- 241000208125 Nicotiana Species 0.000 claims 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 150000007523 nucleic acids Chemical group 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 210000001236 prokaryotic cell Anatomy 0.000 claims 2
- 238000003127 radioimmunoassay Methods 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 230000001131 transforming effect Effects 0.000 claims 2
- 230000009261 transgenic effect Effects 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 238000002965 ELISA Methods 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 238000009825 accumulation Methods 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 238000004220 aggregation Methods 0.000 claims 1
- 230000002776 aggregation Effects 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000001268 conjugating effect Effects 0.000 claims 1
- 241001233957 eudicotyledons Species 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 238000005206 flow analysis Methods 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000001114 immunoprecipitation Methods 0.000 claims 1
- 230000002480 immunoprotective effect Effects 0.000 claims 1
- 230000010354 integration Effects 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 238000000159 protein binding assay Methods 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
- 238000001262 western blot Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87151806P | 2006-12-22 | 2006-12-22 | |
| PCT/US2007/088512 WO2008143713A2 (en) | 2006-12-22 | 2007-12-21 | Plant-made west nile virus (wnv) vaccines, vectors and plant codon optimized sequences |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010514698A JP2010514698A (ja) | 2010-05-06 |
| JP2010514698A5 true JP2010514698A5 (OSRAM) | 2011-04-07 |
Family
ID=40032322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009543249A Pending JP2010514698A (ja) | 2006-12-22 | 2007-12-21 | 植物によって製造されるウエストナイルウイルス（ｗｎｖ）ワクチン、ベクターおよび植物コドン最適化配列 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7888069B2 (OSRAM) |
| EP (1) | EP2099916A2 (OSRAM) |
| JP (1) | JP2010514698A (OSRAM) |
| AR (1) | AR064500A1 (OSRAM) |
| AU (1) | AU2007353773A1 (OSRAM) |
| BR (1) | BRPI0721141A2 (OSRAM) |
| CA (1) | CA2671934A1 (OSRAM) |
| WO (1) | WO2008143713A2 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2944690T3 (pl) * | 2010-10-11 | 2018-05-30 | Jennewein Biotechnologie Gmbh | Nowe fukozylotransferazy i ich zastosowanie |
| WO2012095874A1 (en) | 2011-01-11 | 2012-07-19 | Enneffe S.R.L. | Adjustable anti -theft device |
| WO2013191997A1 (en) * | 2012-06-18 | 2013-12-27 | Dow Agrosciences Llc | Expression of maize codon optimized proteins in pseudomonas fluorescens |
| GB201704126D0 (en) * | 2017-03-15 | 2017-04-26 | Blom Nihlén Kim Andrea | Vaccine |
| US12443985B2 (en) | 2022-12-16 | 2025-10-14 | Sap Se | Solving sparse data problems in a recommendation system with cold start |
| US12430678B2 (en) * | 2022-12-16 | 2025-09-30 | Sap Se | Solving sparse data problems in a recommendation system with freezing start |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5428147A (en) * | 1983-04-15 | 1995-06-27 | Mycogen Plant Science, Inc. | Octopine T-DNA promoters |
| US5380831A (en) * | 1986-04-04 | 1995-01-10 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene |
| US5637489A (en) * | 1986-08-23 | 1997-06-10 | Hoechst Aktiengesellschaft | Phosphinothricin-resistance gene, and its use |
| US5276268A (en) * | 1986-08-23 | 1994-01-04 | Hoechst Aktiengesellschaft | Phosphinothricin-resistance gene, and its use |
| US5273894A (en) * | 1986-08-23 | 1993-12-28 | Hoechst Aktiengesellschaft | Phosphinothricin-resistance gene, and its use |
| US5336603A (en) * | 1987-10-02 | 1994-08-09 | Genentech, Inc. | CD4 adheson variants |
| DE3924454A1 (de) * | 1989-07-24 | 1991-02-07 | Cornelis P Prof Dr Hollenberg | Die anwendung von dna und dna-technologie fuer die konstruktion von netzwerken zur verwendung in der chip-konstruktion und chip-produktion (dna chips) |
| US5073627A (en) * | 1989-08-22 | 1991-12-17 | Immunex Corporation | Fusion proteins comprising GM-CSF and IL-3 |
| CA2071943C (en) | 1989-12-22 | 2007-04-24 | Joan Tellefsen Odell | Site-specific recombination of dna in plant cells |
| US5183740A (en) * | 1990-02-23 | 1993-02-02 | The United States Of America As Represented By The Secretary Of The Navy | Flow immunosensor method and apparatus |
| US5384253A (en) * | 1990-12-28 | 1995-01-24 | Dekalb Genetics Corporation | Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
| IL99120A0 (en) * | 1991-08-07 | 1992-07-15 | Yeda Res & Dev | Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them |
| US6419931B1 (en) * | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
| US6025165A (en) * | 1991-11-25 | 2000-02-15 | Enzon, Inc. | Methods for producing multivalent antigen-binding proteins |
| EP1136556B1 (en) | 1991-11-25 | 2005-06-08 | Enzon, Inc. | Method of producing multivalent antigen-binding proteins |
| TW261517B (OSRAM) * | 1991-11-29 | 1995-11-01 | Mitsubishi Shozi Kk | |
| WO1993023434A2 (en) * | 1992-05-19 | 1993-11-25 | Xoma Corporation | Bpi-immunoglobulin fusion proteins |
| AU673859B2 (en) | 1992-10-05 | 1996-11-28 | North Carolina State University | Method for increasing expression and reducing expression variability of foreign genes in plant cells |
| US6239328B1 (en) * | 1992-10-05 | 2001-05-29 | North Carolina State University | Method for reducing expression variability of transgenes in plant cells |
| CA2146559A1 (en) | 1992-10-23 | 1994-05-11 | Melanie K. Spriggs | Methods of preparing soluble, oligomeric proteins |
| WO1994012520A1 (en) * | 1992-11-20 | 1994-06-09 | Enzon, Inc. | Linker for linked fusion polypeptides |
| FI92882C (fi) * | 1992-12-29 | 1995-01-10 | Medix Biochemica Ab Oy | Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi |
| US5753439A (en) * | 1995-05-19 | 1998-05-19 | Trustees Of Boston University | Nucleic acid detection methods |
| US5843464A (en) * | 1995-06-02 | 1998-12-01 | The Ohio State University | Synthetic chimeric fimbrin peptides |
| US5750352A (en) * | 1995-08-23 | 1998-05-12 | The Johns Hopkins University | Mono-allelic mutation analysis for identifying germline mutations |
| US5773695A (en) * | 1996-01-26 | 1998-06-30 | North Carolina State University | Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells |
| US6277375B1 (en) * | 1997-03-03 | 2001-08-21 | Board Of Regents, The University Of Texas System | Immunoglobulin-like domains with increased half-lives |
| WO1998049305A1 (en) | 1997-05-01 | 1998-11-05 | Amgen Inc. | Chimeric opg polypeptides |
| US6214545B1 (en) * | 1997-05-05 | 2001-04-10 | Third Wave Technologies, Inc | Polymorphism analysis by nucleic acid structure probing |
| HUP0003601A3 (en) * | 1997-08-05 | 2003-03-28 | Stressgen Biotechnologies Corp | Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| US6319691B1 (en) * | 1999-06-15 | 2001-11-20 | Usa Universe Bioengineering, Inc. | Fusion proteins comprising IFN-alpha2b and TM-alpha1 |
| US6342362B1 (en) * | 1999-08-05 | 2002-01-29 | Daniel S. Mytelka | Methods and compositions for the purification of proteins or other macromolecules |
| KR101150584B1 (ko) * | 2002-11-15 | 2012-06-27 | 사노피 파스테르 바이오로직스 씨오 | 웨스트 나일 바이러스 백신 |
| AU2004235800B2 (en) * | 2003-05-05 | 2010-02-18 | Dow Agrosciences Llc | Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
| US8475808B2 (en) | 2003-05-23 | 2013-07-02 | Novartis Vaccines And Diagnostics, Inc. | Immunogenic reagents from west nile virus |
| US20080034455A1 (en) * | 2004-05-21 | 2008-02-07 | Simon Fraser University | Production Of A Protein Localized To The Endoplasmic Reticulum Protein Bodies In A Transgenic Plant And Seed |
-
2007
- 2007-12-21 EP EP07874382A patent/EP2099916A2/en not_active Withdrawn
- 2007-12-21 JP JP2009543249A patent/JP2010514698A/ja active Pending
- 2007-12-21 BR BRPI0721141-4A patent/BRPI0721141A2/pt not_active Application Discontinuation
- 2007-12-21 AR ARP070105865A patent/AR064500A1/es not_active Application Discontinuation
- 2007-12-21 US US11/962,924 patent/US7888069B2/en not_active Expired - Fee Related
- 2007-12-21 WO PCT/US2007/088512 patent/WO2008143713A2/en not_active Ceased
- 2007-12-21 CA CA002671934A patent/CA2671934A1/en not_active Abandoned
- 2007-12-21 AU AU2007353773A patent/AU2007353773A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009540801A5 (OSRAM) | ||
| JP2010514698A5 (OSRAM) | ||
| JP2009529868A5 (OSRAM) | ||
| JP2008545393A5 (OSRAM) | ||
| CN104558108A (zh) | 小反刍兽疫病毒n蛋白的线性抗原表位最小基序肽 | |
| CN117821469A (zh) | 一种鸡trim45截短体重组蛋白或其多克隆抗体的应用 | |
| CN102633867A (zh) | 抗原性改变的肠毒素c2突变体及编码基因与制备和应用 | |
| JP2002515249A5 (OSRAM) | ||
| CN115772230A (zh) | 一种rsv重组抗原、其制备方法及应用 | |
| CN102242083B (zh) | 抗新i型鸭肝炎病毒3d蛋白单克隆抗体 | |
| CN104911195A (zh) | 一种修饰的抗狂犬病病毒HEP-Flury株M蛋白及其单克隆抗体的制备和应用 | |
| CN113583141B (zh) | 猪流行性腹泻病毒Nsp9蛋白、含该Nsp9蛋白的融合蛋白及其制备方法和应用 | |
| JP2013502217A5 (OSRAM) | ||
| CN107034225B (zh) | 制备埃博拉病毒糖蛋白与基质蛋白融合突变体的方法 | |
| CN117264075A (zh) | 一种猪流行性腹泻病毒多表位融合蛋白及其制备方法和应用 | |
| CN118221831A (zh) | 一种鸭肝炎病毒多表位融合蛋白及其应用 | |
| CN102643335A (zh) | 重组轮状病毒vp6载体蛋白及其制备 | |
| CN116942805A (zh) | 一种新型布尼亚病毒Gn糖蛋白疫苗及其应用 | |
| CN116514954A (zh) | 鸡白细胞介素-9受体的单克隆抗体制备与应用 | |
| CN107746848B (zh) | 重组猪瘟病毒e2蛋白及其表达细胞系、制备方法、应用及猪瘟病毒亚单位疫苗 | |
| CN116217717B (zh) | 一种鸭坦布苏病毒多克隆抗体及其制备方法 | |
| CN114805609B (zh) | 一种猪瘟病毒e2-e0融合蛋白、制备方法及应用 | |
| Minina et al. | Immunological detection of plant protein At-4/1 capable of interaction with viral movement proteins. | |
| CN111732667B (zh) | 小反刍兽疫病毒基因工程亚单位疫苗 | |
| CN110734492B (zh) | 抗f4/80的多克隆抗体及制备方法 |